Status: current, Primitive. Date: 31-Jul 2015. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3044264018 | Obinutuzumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3044436014 | Obinutuzumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Obinutuzumab | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Obinutuzumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Obinutuzumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Obinutuzumab only product | Has active ingredient | True | Obinutuzumab | Inferred relationship | Some | 1 |
| Obinutuzumab only product in parenteral dose form | Has active ingredient | True | Obinutuzumab | Inferred relationship | Some | 1 |
| Obinutuzumab 25 mg/mL solution for infusion | Has precise active ingredient | True | Obinutuzumab | Inferred relationship | Some | 1 |
| Obinutuzumab 25 mg/mL solution for infusion | Has BoSS | True | Obinutuzumab | Inferred relationship | Some | 1 |
| Obinutuzumab-containing product | Has active ingredient | True | Obinutuzumab | Inferred relationship | Some | 1 |
| Obinutuzumab-containing product in parenteral dose form | Has active ingredient | True | Obinutuzumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR